MIAMI--(BUSINESS WIRE)--Carisk Partners (formerly Concordia Care, Inc.) a specialty risk transfer, care coordination company, is thrilled to announce that Alana Letourneau, M.D., MBA, Vice President of Clinical Strategy, was selected for the 2018 NJBIZ Forty Under 40 Awards honoring young professionals under the age of 40 for their success and demonstration of strong leadership both within and outside of their chosen field. In her role at Carisk Partners, Dr. Letourneau oversees the Quality Team, which uses data analytics, evidence-based guidelines, research and technology to define quality clinical practices.
“At age 29, Dr. Letourneau amazes me! She is already one of the most talented physician leaders in the specialty health industry and is well-deserving of this award,” says Joseph Berardo Jr., CEO, Carisk Partners, noting that the selection followed a nomination process and evaluation by an independent panel of judges to recognize five honorees in each of eight categories, including healthcare. “She is not only a compassionate champion of patient-focused care, but also has incredible experience with neuroscience research and health technology that focus on applying data to clinical decision-making. Always with a smile, she is a creative and inspiring leader who embodies an entrepreneurial spirit that is fundamental to our team’s ongoing market success.”
Among her current projects, Dr. Letourneau is developing a risk tool for early identification and intervention of both worker’s compensation and behavioral health populations, using machine learning and artificial intelligence. She also supports business development activities, industry partner relationship building, and state government bidding processes. She is a regular presenter for Carisk Partners, and participated at the NJBIZ Opioid Panel, Florida RIMS Educational Conference, and the Advanced Medical Strategies Claims Symposium.
Dr. Letourneau earned her Medical Degree (MD) at New York University School of Medicine, where she was named a Raymond Brienza Scholar, Health Disparities Research Fellow, and Department of Medicine Awardee in Healthcare Dilemmas. Concurrently, she earned an MBA from the NYU Stern School of Business, where she specialized in the Management of Technology and Operations with a focus in data analytics. She was the recipient of the Armando John Garville Scholarship and named to the Dean’s List.
Dr. Letourneau holds a BA from Princeton University where she majored in Psychology, concentrated in Neuroscience and minored in Global Health and Health Policy. She graduated summa cum laude and was awarded the George A. Miller Cognitive Science Prize, Global Health Senior Thesis Prize, Henry Luce Scholarship and Scheide Scholarship.
Accepting this honor, Dr. Letourneau says, “I am personally humbled by this award and the distinction that it carries. My commitment to improving complex case outcomes through addressing biological, psychological and social determinants of health is shared by every member of my organization.”
About Carisk Partners
Carisk (formerly Concordia Care, Inc) is a specialty risk transfer, care coordination company serving insurers, government entities, self-insured plan sponsors and other managed care organizations. With a foundation in behavioral health, Carisk’s combined end-to-end solutions include risk-transfer and care coordination of delayed recovery and complex, catastrophic cases. Carisk guarantees to improve outcomes and reduce long-term cost of care for its clients by leveraging its biopsychosocial methods, extensive networks of quality providers and proprietary technologies modeled for the early identification and intervention of high-risk patients. Carisk is the first and only Managed Behavioral Healthcare Organization with dual accreditations from both the National Committee for Quality Assurance (NCQA) and the Accreditation Association for Ambulatory Healthcare, Inc. (AAAHC). Visit www.cariskpartners.com to learn more.
